Celebrex Articles

Celebrex Suits May Suffer After Judge's Ruling

On Monday, a federal judge ruled to exclude certain experts from testifying on behalf of plaintiffs against the maker of the arthritis drug Celebrex.

Celebrex Kills Cancer?

A new study conducted at the University of Iowa shows that Celebrex aids in killing cancer cells.

Maker of Celebrex in Trouble Again

Five people in Madison County filed a 27-count complaint earlier this month alleging that they suffered heart attacks, strokes, and financial damages as a result of taking the pain-reliever Celebrex.

Heart Attack Victim Files Suit against Drug Manufacturer

A Madison County woman has filed suit against Pfizer, the maker of Bextra, alleging that she suffered a heart attack as a result of taking the drug for more than six months.

Vioxx Maker Seeks FDA Approval on New Arthritis Drug

Merck, the company responsible for manufacturing the controversial arthritis drug Vioxx, is seeking FDA approval on a new arthritis medicine called Arcoxia.

Consumer Group Calls Commercial for Arthritis Drug Misleading

A consumer advocacy group has asked that a new commercial for the arthritis medication Celebrex be banned because it downplays the risks of the drug.

FDA Approves Celebrex for Treatment of Juvenile Arthritis

Pfizer’s COX-2 inhibitor, the only of its type not withdrawn from the market for safety reasons, has been given the green light as a treatment for the painful childhood disease.

British Study May Reveal Root of Adverse Vioxx Side Effects

Researchers have discovered a previously undiscovered effect of COX-2 inhibitors that may explain the apparent increased risk of heart attack and stroke in patients taking Vioxx and other similar medications.

Boston U. Study Finds Link Between Anti-Inflammatory Drug and Heart Attacks

According to researchers at the Boston Collaborative Drug Surveillance Program, a link has been discovered between the anti-inflammatory medication diclofenac and an increased risk of heart attacks.

Celebrex ads return, accompanied by serious warnings

Pfizer has revamped and resumed their ad campaign for the controversial arthritis pain medication Celebrex, 16 months after the company voluntarily halted advertising.

Frist Proposes Banning Pharmaceutical Advertising to Consumers

New York -- The Senate Majority Leader suggested that pharmaceutical companies voluntarily impose a two-year ban on direct-to-consumer advertising.

SEC Requests Documents on Bextra and Celebrex

Pfizer Inc. recently announced that the Securities and Exchange Commission (SEC) has requested documents and information on its painkillers Bextra and Celebrex.

New Study Suggests Patients Should Stop Taking NSAIDS before Gum Surgery

A recent study suggests that patients should stop taking non-steroidal anti-inflammatory drugs (NSAID'S) such as Ibuprofen and Celebrex, prior to having gum surgery.

New Celebrex Label Approved

The Federal Drug Administration (FDA) has completed approval for label changes for the drug Celebrex.

Nonsteroidal Anti-Inflammatory Drugs May Lead To Urinary Retention

According to Dutch researchers, the use of nonsteroidal anti-inflammatory drugs (NSAIDS) such as Naproxen (Aleve), Celebrex and Ibuprofen may double the risk of acute urinary retention.

Clinical trials for treatment of lung cancer with Celebrex resume

Researchers at the University of Texas M.D. Anderson Cancer Center in Houston have resumed trials on the drug Celebrex. The trials will study the effectiveness of the drug in preventing lung cancer in former and current smokers.

The Dangers of Defective Prescription Drugs

The U.S. Food and Drug Administration diligently regulates and monitors the dangers of prescription and non-prescription drugs in America. And every year the FDA forces drug manufacturers to recall hundreds of medications from pharmacy shelves.